MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
Recruiting · NCT06319248 · Registry updated 2026-08-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, cardiovascular disorder, hypotensive disorder, vascular disorder | Recruiting | Phase 2 | 2026-08-31 | NCT06319248 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Mayo Clinic | 970 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic Arizona | Scottsdale | United States | 34 |
| Mayo Clinic Florida | Jacksonville | United States | 105 |
| Mayo Clinic Health System - Eau Claire | Eau Claire | United States | 2 |
| Mayo Clinic Health System - Mankato | Mankato | United States | 6 |
| Mayo Clinic Minnesota | Rochester | United States | 40 |